×
About 583,250 results

Lingering Effects Seen With Non-COVID Respiratory Illness Too
https://www.medpagetoday.com/infectiousdisease/covid19/102011

Dec 1st, 2022 - People with acute respiratory illness during the pandemic suffered similar levels of poor well-being in the months afterward whether they tested positive for SARS-CoV-2 or not, a registry study showed. In a cohort of people who all had initial symptoms suggestive of COVID-19, those who had moderate to severe scores at 3 months on the pain, mood, and other quality-of-life measures on the Patient...

Experts Look to Shield Students From Cracks in Mental Health Care
https://www.medpagetoday.com/psychiatry/generalpsychiatry/102010

Dec 1st, 2022 - Experts discussed the obstacles to caring for young people with mental health problems as they transition from high school to college during a hearing of the Senate Health, Education, Labor, and Pensions (HELP) Subcommittee on Children and Families on Wednesday. Witnesses pressed Congress to invest more in the treatments for first-episode psychosis and to increase education on more serious and ...

Overactive Bladder Linked to Multiple Unmet Socioeconomic Needs
https://www.medpagetoday.com/urology/urology/102005

Dec 1st, 2022 - Unmet socioeconomic needs had a significant association with overactive bladder (OAB), adding to evidence of a complex interaction between social determinants of health and OAB, researchers said. Stressors such as housing and food insecurity and concerns about personal health as much as tripled the odds of reported OAB symptoms. The stressors remained significant predictors for OAB after adjust...

Unique Nationwide Screening Program Fails to Move the Needle on CVD Risk Factors
https://www.medpagetoday.com/primarycare/preventivecare/102002

Dec 1st, 2022 - Japan's mass screening and counseling intervention resulted in only modest population-wide improvements in obesity and cardiovascular disease (CVD) risk factors, a study showed. Among over 3.4 million men and 2.3 million women, those who met the threshold for high waist circumference with high blood pressure, impaired glucose tolerance, or dyslipidemia and received lifestyle guidance and counse...

Year in Review: Diffuse Large B-Cell Lymphoma
https://www.medpagetoday.com/hematologyoncology/lymphoma/101996

Dec 1st, 2022 - Second-line treatment for diffuse large B-cell lymphoma (DLBCL) got a big boost in 2022 with new indications for a pair of chimeric antigen receptor (CAR) T-cell therapies, while an antibody-drug conjugate moved one step closer to shaking up treatment in the first-line setting. CAR-T Products Move to Second-Line In April, axicabtagene ciloleucel (axi-cel; Yescarta) became the first CAR T-cell t...

Four Eyes Are Not Better Than Two for COVID-19 Protection
https://www.medpagetoday.com/infectiousdisease/covid19/101995

Dec 1st, 2022 - Wearing glasses in public for 2 weeks did not protect against SARS-CoV-2 infection, a Norwegian pragmatic randomized trial showed. Among more than 3,700 participants, 3.7% of those randomized to wear sunglasses or other types of glasses in the community reported a positive COVID test to the Norwegian Surveillance System for Communicable Diseases compared with 3.5% of those in the control group ...

Top 10 Unproven Infertility Tests and Treatments
https://www.medscape.com/viewarticle/984553

Dec 1st, 2022 - In 2019, a New York Times opinion piece titled, “The Big IVF Add-On Racket – This is no way to treat patients desperate for a baby”[1] alleged exploitation of infertility patients based on a Fertility and Sterility article, “Do à la carte menus serve infertility patients? The ethics and regulation of in vitro fertility add-ons.”[2] The desperation of infertility patients combined with their fin...

Can Cannabis Help Patients With MS?
https://www.medscape.com/viewarticle/977034

Dec 1st, 2022 - This transcript has been edited for clarity. Anne Cross, MD: Hello. I'm Anne Cross. Welcome to Medscape's InDiscussion series on multiple sclerosis. And today we're going to take on the somewhat controversial topic of the use of cannabis and cannabinoids in the treatment of symptoms in patients with multiple sclerosis. We have an expert to speak to us today about this, Dr Jacquelyn Bainbridge, ...

'Call to Action' for DPYD Testing Before Fluorouracil Chemo
https://www.medscape.com/viewarticle/984799

Dec 1st, 2022 - The debate over whether or not to test for DPYD gene variants before administering fluoropyrimidine (FP) chemotherapy has erupted again among experts in the United States, where such testing is not recommended at present, unlike in Europe. Testing for DPYD variants and subsequent dose adjustment should be offered to US patients who are due to receive fluoropyrimidine chemotherapy, says Daniel L...

Fewer Neonatal Risks With Buprenorphine for Opioid Use Disorder in Pregnancy
https://www.medpagetoday.com/obgyn/pregnancy/101994

Dec 1st, 2022 - Buprenorphine treatment for pregnant patients with opioid use disorder (OUD) was linked with fewer neonatal risks compared with methadone therapy, but had similar maternal outcomes, an analysis of Medicaid data found. Neonatal abstinence syndrome (NAS) occurred in 52% of infants whose mothers took buprenorphine in the 30 days before delivery compared with 69% of those whose mothers took methado...

Simulated Driver Training May Reduce Accidents Among Teens With ADHD
https://www.medpagetoday.com/pediatrics/adhd-add/101986

Nov 30th, 2022 - A simulated driving program reduced inattention and risk of crashing among teens with attention deficit-hyperactivity disorder (ADHD) compared with conventional driver's training, according to a small study that used a program combining computer-based and driving simulator training. During 15-minute simulated drives, teens in the training group had a mean of 16.5 long glances (>2 seconds) from ...

Higher BMI a Risk Factor for Long COVID Symptoms
https://www.medpagetoday.com/primarycare/longcovid/101981

Nov 30th, 2022 - When it comes to developing long COVID, certain people may have a higher risk than others, researchers reported. According to an online survey of people who tested positive in 2020, 52.1% said they experienced post-COVID syndrome symptoms, said Vassilios Vassiliou, PhD, of the University of East Anglia in Norwich, England, and colleagues. One of the top predictors of exactly who might develop t...

Research - Acinetobacter baumannii among Patients Receiving Glucocorticoid Aerosol Therapy during Invasive Mechanical Ventilation, China
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732835

Aerosolized glucocorticoid treatment was independently associated with bacterial isolation in these patients.

One in Three Patients With Unstable Pelvic Fractures Die, Study Shows
https://www.medpagetoday.com/criticalcare/generalcriticalcare/101973

Nov 30th, 2022 - Despite use of advanced hemorrhage control interventions, more than one in three patients with hemodynamically unstable pelvic fractures died, a retrospective cohort study showed. Among nearly 1,400 patients who received early transfusions and at least one invasive pelvic hemorrhage control intervention, the 24-hour mortality rate was 15.5%, the emergency department mortality rate was 0.7%, and...

Alzheimer's Drug Slows Decline, Trial Data Show
https://www.medpagetoday.com/neurology/alzheimersdisease/101972

Nov 30th, 2022 - Treatment with the investigational anti-amyloid agent lecanemab led to modestly less decline on cognitive and functional measures in the phase III CLARITY AD trial of early Alzheimer's disease, but was associated with adverse events. From a baseline score of about 3.2 on the Clinical Dementia Rating-Sum of Boxes (CDR-SB), mean worsening at 18 months was 1.21 with lecanemab and 1.66 with placebo...

Monks and Meth; China Says Jogger Caused COVID Outbreak; Flu Deaths Close to 3,000
https://www.medpagetoday.com/infectiousdisease/covid19/101971

Nov 30th, 2022 - Note that some links may require subscriptions. All four monks at a Buddhist temple in central Thailand were defrocked after testing positive for methamphetamine use. (CBS News) New York City will begin involuntarily hospitalizing its homeless mentally ill residents, Mayor Eric Adams (D) said. (New York Times) A Minnesota woman lost part of her peripheral vision and inadvertently put her family...

Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for some becomes focus
https://www.reuters.com/article/eisai-biogen-alzheimers/eisai-biogen-alzheimers-drug-slows-cognitive-decline-safety-for-some-becomes-focus-idUSL1N32O1QW

Nov 30th, 2022 - SAN FRANCISCO, Nov 29 (Reuters) - An experimental Alzheimer’s disease drug from Eisai and Biogen slowed cognitive decline in a closely-watched trial but may carry a risk of dangerous side effects for certain patients, according to new data presented on Tuesday. The drug, lecanemab, was associated with a type of brain swelling in 12.6% of trial patients, a side effect previously seen with simila...

The 'Too Many Toes Sign' and the Thompson Squeeze
https://www.medscape.com/viewarticle/984256

Nov 30th, 2022 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, here with my great friend Dr Paul Nelson Williams. Today we're going to be talking about foot and ankle pain. We had a great podcast episode on this, The Thrill of Victory and the Agony of the Feet, with Dr Joan Ritter. Paul, let's start with ankle sprains. Give me a pearl. P...

China to Ramp Up COVID Vaccinations for Its Elderly
https://www.medscape.com/viewarticle/984704

Nov 30th, 2022 - BEIJING (Reuters) -China will speed up COVID-19 vaccinations for elderly people, health officials said on Tuesday, aiming to overcome a key stumbling block in efforts to ease unpopular "zero-COVID" curbs. The move is seen as a crucial element in a strategy to unwind nearly three years of strict curbs that have eroded economic growth, disrupted the lives of millions, and sparked unprecedented we...

New Framework for Multiple Sclerosis Diagnosis, Treatment Proposed
https://www.medscape.com/viewarticle/984749

Nov 30th, 2022 - An international panel of experts has proposed a new way to classify multiple sclerosis (MS) that would ultimately change the way patients are diagnosed and treated. The goal is to eventually move away from the current system, which classifies MS based on disease progression into distinct relapsing-remitting, secondary progressive, and primary progressive subtypes. Members of the International ...